Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1693–1728
Headlines
2785
Sources here
14
Companies here
23
Current section United States Medical Instruments & Supplies news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Intuitive Surgical (ISRG) Faces Global Recall Of 11,113 Da Vinci SP Drapes

Intuitive Surgical (ISRG) is facing a global Class II recall of 11,113 da Vinci SP Instrument Arm Drapes due to detachment issues that could delay procedures or require changes in surgical approach. This recall, affecting its robotic surgery platform, highlights operational and regulatory risks …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit

This article summarizes changes in analyst ratings and price targets for several U.S.-listed companies as reported by Reuters on a Friday. Key changes include Stephens cutting BioLife Solutions to equal weight, Leerink Partners raising Gossamer Bio to outperform, and TD Cowen cutting Intuit to …

BLFS main company
Sharemaestro market context Trend signal active 52 weeks +35.4% BLFS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bionano Genomics Inc (BNGO) Institutional Confidence

Bionano Genomics Inc (BNGO) has an institutional shareholding score of 3.00, placing it 130th out of 199 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion increased by 354.71% quarter-over-quarter to 10.52%. James Simons is the largest institutional shareholder, holding 0.44% of …

BNGO main company
Sharemaestro market context Price below Trend Line 52 weeks -70.5% · Next-week setup negative 36.9% BNGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resmed Inc (RMD) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Resmed Inc (RMD), noting its current valuation score of 8.67, which ranks 72 out of 199 in the Healthcare Equipment & Supplies industry. The P/E ratio for RMD is reported as 20.07, indicating it is below its …

RMD main company
Sharemaestro market context Price above Trend Line 52 weeks -23.0% RMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UC co-op helps build career pathways at AtriCure

The article highlights the strong partnership between the University of Cincinnati's co-op program and AtriCure, a medical device company. Many UC students, especially in biomedical engineering, gain invaluable real-world experience at AtriCure, with numerous alumni continuing to work there full-time. This collaboration provides significant …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AngioDynamics Inc (ANGO) Institutional Confidence

AngioDynamics Inc (ANGO) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 93.94%, a decrease of 11.97% quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 3.06 million shares, despite a …

ANGO main company
Sharemaestro market context Trend signal active 52 weeks +67.7% ANGO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BDX.GJ Bond Profile — Key Metrics

This article provides a detailed profile of the BDX.GJ bond issued by Becton, Dickinson & Co. It outlines key metrics such as the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. The bond's profile is focused on the …

BDX main company
Sharemaestro market context Price above Trend Line 52 weeks +19.7% · Next-week setup negative 33.9% BDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Microbot Medical Inc (MBOT) Institutional Confidence

Microbot Medical Inc (MBOT) has an institutional shareholding score of 3.00, placing it 192nd out of 385 in the Biotechnology & Medical Research industry. Institutional shareholding proportion increased by 41.23% quarter-over-quarter to 23.09%. Key institutional shareholders include CIBC Private Wealth Advisors, Inc., Susquehanna International …

MBOT main company
Sharemaestro market context Price below Trend Line 52 weeks -59.7% MBOT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALIGN TECHNOLOGY ($ALGN) Releases Q2 2026 Earnings

This article first appeared on GuruFocus. Revenue: Record Q2 2026 revenue of $1.06 billion, up 4.3% year-over-year. Clear Aligner Revenue: $870.9 million, up 8.2% year-over-year. Clear Aligner Volume: Record 692,000 cases, up 7.4% year-over-year. Clear Aligner ASP: $1,260 per case, up 0.8% year-over-year. Systems …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bausch + Lomb Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:BLCO) 2026-07-29

Bausch + Lomb (BLCO) reported strong Q2 2026 results, with an 8% constant currency revenue growth and a 28% increase in adjusted EBITDA, leading to a 17.6% adjusted EBITDA margin. The company raised its full-year revenue and adjusted EBITDA guidance, driven by consistent performance …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bausch + Lomb (NYSE:BLCO) Exceeds Q2 CY2026 Expectations

Bausch + Lomb (NYSE:BLCO) Exceeds Q2 CY2026 Expectations Eyecare company Bausch + Lomb (NYSE:BLCO) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 9.1% year on year to $1.39 billion. The company expects the full year's revenue to be around …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zentek Ltd (ZTEK) Financial Health: Profitability & Balance Sheet Analysis

Zentek Ltd (ZTEK) currently has a financial score of 6.65, ranking 234 out of 385 in the Biotechnology & Medical Research industry, indicating a weak financial status and low operating efficiency. Its latest quarterly revenue significantly decreased by 96.82% year-over-year, while net profit fell …

ZTEK main company
Sharemaestro market context Price above Trend Line 52 weeks -10.9% · Next-week setup negative 36.2% ZTEK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bausch + Lomb: Q2 Earnings Snapshot

Bausch + Lomb Corporation reported a Q2 loss of $14 million, or 4 cents per share, which adjusted to 16 cents per share, meeting Wall Street expectations. The company recorded revenue of $1.39 billion, exceeding analyst forecasts, and anticipates full-year revenue between $5.42 billion …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

KORU Medical Systems, Inc. Revenue Breakdown – NASDAQ:KRMD

KORU Medical Systems, Inc. (NASDAQ: KRMD) generated $41.13 million USD in revenue last year. The "Domestic Core" segment was the top performer, contributing $27.99 million USD, an increase from $25.21 million USD in the prior year. The United States was the largest geographical contributor, …

KRMD main company
Sharemaestro market context Price below Trend Line 52 weeks -22.4% KRMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cooper Companies Inc (COO) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article presents a risk assessment for Cooper Companies Inc (COO), highlighting its current risk score and beta value. The company ranks 22 out of 199 in the Healthcare Equipment & Supplies industry with a beta of 0.88, suggesting it is less volatile than …

COO main company
Sharemaestro market context Price above Trend Line 52 weeks +1.3% COO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Microbot Medical Inc (MBOT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Microbot Medical Inc (MBOT), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. As of July 28, 2026, MBOT's stock is trading between resistance at $1.93 and …

MBOT main company
Sharemaestro market context Price below Trend Line 52 weeks -59.7% MBOT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Innovative Eyewear Inc (LUCY) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Innovative Eyewear Inc (LUCY), noting its current score of 6.60, which ranks 148 out of 199 in its industry. The company demonstrated robust financial status with a significant year-over-year revenue increase of 70.20% and a net …

LUCY main company
Sharemaestro market context Price below Trend Line 52 weeks -63.1% · Next-week setup negative 33.2% LUCY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resmed Inc (RMD) Financial Health: Profitability & Balance Sheet Analysis

Resmed Inc (RMD) has a strong financial health score of 9.76, placing it first in the Healthcare Equipment & Supplies industry. The company reported a quarterly revenue of $1.43 billion, marking a 10.81% year-over-year increase, and net profit grew by 9.23% year-over-year. Key financial …

RMD main company
Sharemaestro market context Price above Trend Line 52 weeks -23.0% RMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICU Medical Inc (ICUI) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for ICU Medical Inc (ICUI), noting its current score of 7.52, ranking 36th in the Healthcare Equipment & Supplies industry. The company's beta of 0.78 suggests it tends to underperform in bull markets but offers greater stability during …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bausch + Lomb Corp (BLCO) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Bausch + Lomb Corp (BLCO), rating its current risk score at 7.06, placing it 43rd out of 199 in the Healthcare Equipment & Supplies industry. Key metrics include a beta of 0.58, indicating lower volatility compared to …

BLCO main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% BLCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Azenta Inc (AZTA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Azenta Inc (AZTA), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. While the stock currently trades between a resistance level of $30.57 and a support level …

AZTA main company
Sharemaestro market context Price above Trend Line 52 weeks +5.8% AZTA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avantor Inc (AVTR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Avantor Inc (AVTR), detailing its volatility, financial metrics, and investment risks. With a risk assessment score of 5.39, Avantor ranks 78 out of 199 in the Healthcare Equipment & Supplies industry and has a beta of 0.97, …

AVTR main company
Sharemaestro market context Trend signal active 52 weeks +2.9% AVTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen Corporation reported strong second-quarter 2026 financial results, with revenue reaching $204 million, marking a 12% year-over-year increase. The company also announced a definitive agreement to acquire BioLife Solutions, aiming to enhance its cell therapy leadership. Following these positive outcomes, Repligen raised its full-year …

RGEN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% RGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings To Watch: Merit Medical Systems (MMSI) Reports Q2 Results Tomorrow

Merit Medical Systems (MMSI) is set to announce its Q2 earnings results after the bell tomorrow. The market anticipates a 6% year-on-year revenue growth. The company has a history of exceeding Wall Street's expectations and has seen positive investor sentiment in the healthcare equipment …

MMSI main company
Sharemaestro market context Price above Trend Line 52 weeks +1.5% MMSI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why is Solventum stock surging today?

Solventum stock surged over 7% today after UBS upgraded the healthcare company from Neutral to Buy, setting a price target of $95. This upgrade, combined with supportive analyst sentiment and an upcoming Q2 2026 earnings report on August 5, pushed Solventum shares towards their …

SOLV main company
Sharemaestro market context Trend signal active 52 weeks +20.4% · Next-week setup negative 34.7% SOLV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context